All News

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Officials with the FDA have approved AstraZeneca’s moxetumomab pasudotox-tdfk (Lumoxiti) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least 2 prior systemic therapies.

A second unexpected impurity was shown in 3 lots of Torrent Pharmaceuticals’ recalled drug products during an ongoing FDA investigation.

The FDA has accepted for review Regeneron Pharmaceuticals’ supplemental Biologics License Application of aflibercept (EYLEA Injection) to treat diabetic retinopathy.

A recent survey evaluated the baseline knowledge of licensed pharmacists with regard to common pet toxins.

Tocilizumab’s newest formulation offers an additional administration option for children diagnosed systemic juvenile idiopathic arthritis, a rare and debilitating disease.

Azathioprine, a drug used to treat a variety of conditions, may contribute to skin cancer development.

More than 65% of patients with Kaposi’s sarcoma in a small cohort had partial or complete remission when treated with immune checkpoint inhibitors.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

B cells activate T cells in the blood to cause inflammation and brain lesions in patients with multiple sclerosis.

One in 5 test results showed potentially dangerous concurrent use of opioids and benzodiazepines in 2017.

A study examined whether silymarin, is an active extract of milk thistle, has a therapeutic effect and can improve hepatic enzyme measures.

A new study examining HIV in people who inject drugs found interventions increased use of antiretroviral medication.

With Hurricane Florence about to strike, pharmacies must take extra steps to maintain services for patients in need of lifesaving medications.

Having an emergency plan helps pharmacists, pharmacies, and patients protect themselves and their medications, during a disaster event and in the aftermath.

Azathioprine is known to cause increased photosensitivity to UVA light, but the new findings indicate an association between the drug and the mutational signature found in cases of cutaneous squamous cell carcinoma.

Early-life obesity increases the risk of several different types of cancer developing later in life.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

In its multiple-ascending dose trial, ARO-HBV demonstrated reductions in circulating hepatitis B virus surface antigen.

Study identifies a potential association between azathioprine and the mutational signature found in cases of cutaneous squamous cell carcinoma.

The FDA is taking new steps to better ensure the quality of compounded drugs, while also preserving patient access to these medications.

Study shows a novel treatment approach that could prevent gene changes associated with the disease.

Top news of the day from across the health care landscape.

Officials with the FDA recently granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma without an eosinophilic phenotype.

Top news of the day from across the health care landscape.

More than half of Americans tested misused their prescription drugs in 2017.